Profile | GDS4284 / 1553096_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 958.443 | 74 |
GSM687648 | Patient 402 control | 965.923 | 73 |
GSM687653 | Patient 403 control | 1398.63 | 79 |
GSM687658 | Patient 404 control | 1344.41 | 78 |
GSM687663 | Patient 411 control | 1310.06 | 78 |
GSM687668 | Patient 422 control | 765.971 | 70 |
GSM687673 | Patient 424 control | 1585.92 | 81 |
GSM687678 | Patient 425 control | 1409.76 | 78 |
GSM687683 | Patient 427 control | 1163.56 | 76 |
GSM687688 | Patient 428 control | 923.762 | 73 |
GSM687695 | Patient 441 control | 1132.69 | 77 |
GSM687699 | Patient 443 control | 681.744 | 68 |
GSM687704 | Patient 444 control | 1225.31 | 77 |
GSM687707 | Patient 448 control | 1334.54 | 79 |
GSM687712 | Patient 449 control | 1219.19 | 77 |
GSM687719 | Patient 450 control | 1275.21 | 78 |
GSM687724 | Patient 451 control | 1182.63 | 77 |
GSM687728 | Patient 452 control | 348.068 | 58 |
GSM687646 | Patient 401 treated 24h | 1166.71 | 76 |
GSM687649 | Patient 402 treated 24h | 1230.15 | 77 |
GSM687665 | Patient 411 treated 24h | 1449.9 | 79 |
GSM687651 | Patient 402 treated 4 weeks | 1260.73 | 77 |
GSM687667 | Patient 411 treated 4 weeks | 1194.12 | 76 |
GSM687670 | Patient 422 treated 24h | 1226.03 | 77 |
GSM687671 | Patient 422 treated 4 weeks | 922.582 | 72 |
GSM687654 | Patient 403 treated 24h | 1148.95 | 76 |
GSM687675 | Patient 424 treated 24h | 1668.61 | 81 |
GSM687685 | Patient 427 treated 24h | 1244.97 | 77 |
GSM687656 | Patient 403 treated 4 weeks | 1409.96 | 79 |
GSM687677 | Patient 424 treated 4 weeks | 1020.24 | 74 |
GSM687687 | Patient 427 treated 4 weeks | 1095.71 | 75 |
GSM687692 | Patient 428 treated 4h | 1028.25 | 74 |
GSM687716 | Patient 449 treated 4h | 1102.78 | 76 |
GSM687722 | Patient 450 treated 4h | 1318.08 | 78 |
GSM687680 | Patient 425 treated 24h | 1801.21 | 82 |
GSM687690 | Patient 428 treated 24h | 899.383 | 73 |
GSM687700 | Patient 443 treated 24h | 1738.24 | 82 |
GSM687705 | Patient 444 treated 24h | 1337.88 | 78 |
GSM687714 | Patient 449 treated 24h | 706.01 | 69 |
GSM687721 | Patient 450 treated 24h | 1729.97 | 82 |
GSM687682 | Patient 425 treated 4 weeks | 1128.64 | 76 |
GSM687694 | Patient 428 treated 4 weeks | 973.051 | 73 |
GSM687702 | Patient 443 treated 4 weeks | 1637.37 | 81 |
GSM687718 | Patient 449 treated 4 weeks | 1107.84 | 76 |
GSM687723 | Patient 450 treated 4 weeks | 1130.28 | 76 |
GSM687661 | Patient 404 treated 4h | 1500.87 | 80 |
GSM687710 | Patient 448 treated 4h | 1700.89 | 82 |
GSM687726 | Patient 451 treated 4h | 926.371 | 73 |
GSM687730 | Patient 452 treated 4h | 2224.59 | 87 |
GSM687660 | Patient 404 treated 24h | 1693.65 | 83 |
GSM687697 | Patient 441 treated 24h | 1364.76 | 79 |
GSM687709 | Patient 448 treated 24h | 960.916 | 74 |
GSM687725 | Patient 451 treated 24h | 1230.96 | 77 |
GSM687729 | Patient 452 treated 24h | 1914.89 | 85 |
GSM687727 | Patient 451 treated 4 weeks | 1101.14 | 75 |
GSM687731 | Patient 452 treated 4 weeks | 1346.65 | 78 |